Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.

Medtronic plc , a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a registration ...

The eighth China International Import Expo (CIIE) has concluded with record results, underscoring its growing global influence and China’s commitment to openness. Over six days, the expo welcomed 922, ...

BROOKLYN CENTER, Minn. — Medtronic is giving a group of international VIPs a rare, behind the scenes tour of its operations this week. In this case, VIP stands for Very Important Patients. "This is ...

FDA has greenlit Medtronic’s Hugo Robotic-Assisted Surgery system for urological surgical procedures, in perhaps one of the biggest regulatory clearances of the year. The move comes a little more than ...

From left to right: Katie Adams, assistant editor at MedCity News; and Jennifer Thompson, vice president of U.S. aortic sales at Medtronic The process of commercializing a new medical device is ...

While there is no cure for Parkinson’s disease, there’s now a better way to control its involuntary muscle movements. In February, the FDA approved Medtronic’s BrainSense adaptive deep brain ...

Medtronic MDT-0.25%decrease; red down pointing triangle is making changes to its board after Elliott Investment Management became one of its largest shareholders. The activist investor and the medical ...

The InPen with Simplera CGM. [Image courtesy of Medtronic] The Spanish Agency for Medicines and Medical Devices (AEMPS) has received notice of potential accessibility issues with Medtronic CGM apps.

Medtronic is separating out its lower-margin diabetes care segment. It's also pouncing on a massive opportunity in robotic-assisted surgery. The healthcare leader has a terrific dividend-growth track ...

On Wednesday, the Centers for Medicare & Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ...

The U.S. Food and Drug Administration (FDA) is aware that Medtronic Plc (NYSE:MDT) and its subsidiary, Given Imaging Inc., have issued two letters to affected customers recommending that certain Bravo ...